SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-12-370859
Filing Date
2012-08-28
Accepted
2012-08-28 09:29:50
Documents
8
Period of Report
2012-08-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d403617d8k.htm 8-K 18020
2 EX-5.1 d403617dex51.htm EX-5.1 14739
3 EX-10.1 d403617dex101.htm EX-10.1 54741
4 EX-10.2 d403617dex102.htm EX-10.2 76063
5 EX-10.3 d403617dex103.htm EX-10.3 109202
6 EX-99.1 d403617dex991.htm EX-99.1 8475
7 GRAPHIC g403617ex99_1logo.jpg GRAPHIC 13800
8 GRAPHIC g403617g87g20.gif GRAPHIC 5952
  Complete submission text file 0001193125-12-370859.txt   310032
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICAL PARTNERS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33057 | Film No.: 121058484
SIC: 2834 Pharmaceutical Preparations